Periodontally Accelerated Osteogenic Orthodontics With BMP2
1 other identifier
interventional
30
1 country
1
Brief Summary
rhBMP-2 has the potential to function as a regenerative material in periodontally accelerated osteogenic orthodontics (PAOO). This study aimed to assess the effects of PAOO with BMP-2 on outcomes such as treatment period, bone density, healing and pain.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_2
Started Jul 2016
Shorter than P25 for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2017
CompletedFirst Submitted
Initial submission to the registry
December 27, 2017
CompletedFirst Posted
Study publicly available on registry
January 11, 2018
CompletedJanuary 11, 2018
January 1, 2018
1.1 years
December 27, 2017
January 4, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Orthodontic treatment duration
Periodic recall of patients for every two weeks was done to assess the amount of crowding relieved by using digital Vernier calipers and photographs. The time taken to unravel the crowding in the pretreatment and post treatment study models and photographs was recorded.
Up to 6 months
Study Arms (2)
RhBMP-2 Protein, Recombinant
ACTIVE COMPARATOR15 subjects treated with corticotomy with rhBMP-2 (C+BMP)
Conventional Corticotomy
EXPERIMENTAL15 subjects treated with conventional corticotomy (C) as in the PAOO protocol
Interventions
Bone morphogenetic proteins (BMPs) are a category of proteins that are involved in bone formation and repair. Among these, BMP-2 is one of the most potent members of the BMP family and has been used for correcting intrabony, supraalveolar, furcation, and fenestration defects due to its osteoinductive property. BMP's are also essential for differentiation of osteoclasts, but their role in this process remains unclear. Treatment of osteoclasts with exogenous BMP-2 directly enhances RANKL-stimulated differentiation of osteoclast precursors in vitro and stimulates survival and resorptive activity of mature osteoclasts that accelerates the tooth movement.
A conventional PAOO Surgical procedure will be performed for individuals in this arm
Eligibility Criteria
You may qualify if:
- subjects with moderate crowding of lower incisors based upon Little's index and willing to undergo undergoing orthodontic treatment with extraction therapy of lower 1st premolars and PAOO were included in the study.
You may not qualify if:
- Smokers and subjects with severe crowding of anterior teeth, periodontitis and systemic diseases were excluded from the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
SVS Institute of Dental Sciences, Mahabubnagar
Hyderabad, Andhra Pradesh, 509002, India
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Madhukar R Rachala, MDS
SVS Institute of Dental Sciences
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Masking Details
- The orthodontist (HA) who performed the relevant treatment after PAOO was different from the orthodontist (MRR) randomizing the subjects into C or C+BMP groups and hence was blinded to the treatment received by the patient. One periodontist performed the PAOO surgeries (KM) and another periodontist (RVC) blinded to the therapy received by the subjects recorded the clinical and radiographic data pertinent to the study. The blind was not broken until the end of study period.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Investigator
Study Record Dates
First Submitted
December 27, 2017
First Posted
January 11, 2018
Study Start
July 1, 2016
Primary Completion
August 1, 2017
Study Completion
November 1, 2017
Last Updated
January 11, 2018
Record last verified: 2018-01
Data Sharing
- IPD Sharing
- Will not share
Published data will be shared